The molecular pathogenesis of Equine rhinitis A virus, a major respiratory pathogen of horses. The equine industry in Australia is worth $15 billion a year. Equine respiratory disease costs Victoria, alone, $5-10 million per year. Equine rhinitis A virus is a major cause of acute febrile respiratory disease in horses. This project aims to develop an infectious clone to study the pathogenesis of the disease, and subunit antigens for use as vaccines. These reagents will increase our understand ....The molecular pathogenesis of Equine rhinitis A virus, a major respiratory pathogen of horses. The equine industry in Australia is worth $15 billion a year. Equine respiratory disease costs Victoria, alone, $5-10 million per year. Equine rhinitis A virus is a major cause of acute febrile respiratory disease in horses. This project aims to develop an infectious clone to study the pathogenesis of the disease, and subunit antigens for use as vaccines. These reagents will increase our understanding of the pathogenesis of ERAV and will lead to experimental vaccines which will be tested in horses.Read moreRead less
Development of an anti-Chlamydia vaccine for the koala. The koala is one of Australia's main icons and a major drawcard for tourists. However, it suffers from debilitating disease due to the bacterium Chlamydia, which can lead to severe conjunctivitis, eventual blindness in both sexes, and the females develop untreatable cysts and can become infertile. This project will develop a Chlamydia vaccine to be administered to healthy and diseased koalas in zoos, sanctuaries, koala care centres, relocat ....Development of an anti-Chlamydia vaccine for the koala. The koala is one of Australia's main icons and a major drawcard for tourists. However, it suffers from debilitating disease due to the bacterium Chlamydia, which can lead to severe conjunctivitis, eventual blindness in both sexes, and the females develop untreatable cysts and can become infertile. This project will develop a Chlamydia vaccine to be administered to healthy and diseased koalas in zoos, sanctuaries, koala care centres, relocation programs and eventually perhaps even wild populations. The vaccine findings may also be transferable to other animals and may also even assist the development of a human Chlamydia vaccine.Read moreRead less
Molecular and antibody analysis of cytomegalovirus (CMV) infection of fetal and placental cells. CMV is a beta herpesvirus with many unknown molecular mechanisms associated with cellular infection. The virus infects placental cells in vivo, although pathogenesis of viral damage to these cells has been extremely difficult to study in vitro. We have commenced a study to i) demonstrate the molecular accompaniments of infection of placental cells in vitro, ii) determine the genotypic characteristics ....Molecular and antibody analysis of cytomegalovirus (CMV) infection of fetal and placental cells. CMV is a beta herpesvirus with many unknown molecular mechanisms associated with cellular infection. The virus infects placental cells in vivo, although pathogenesis of viral damage to these cells has been extremely difficult to study in vitro. We have commenced a study to i) demonstrate the molecular accompaniments of infection of placental cells in vitro, ii) determine the genotypic characteristics of congenital CMV infections, in collaboration with Abbott Diagnostics, and iii) produce an in vivo model of CMV infection to demonstrate the pathogenesis of cellular injury. The combination of molecular expertise at UNSW with monoclonal antibody expertise from Abbott Diagnostics mean this project is unique worldwide.Read moreRead less
Proteomics and vaccine development in swine dysentery. Swine dysentery is an infectious disease of significant economic importance caused by Brachyspira hyodysenteriae. There is no effective vaccine available. This project will combine modern techniques in microbial genomics and proteomics to identify outer membrane proteins of B. hyodysenteriae and evaluate their role as candidate vaccine antigens.
Subspecies distribution and virulence of Streptococcus uberis. Streptococcus uberis is a significant cause of bovine mastitis. Attempts to produce a successful vaccine against S. uberis have been hampered by the lack of knowledge of phylogenetic relationships within the species and virulence mechanisms. It is uncertain whether pathogenic strains are clonal or are acquired opportunistically from a diverse population in the environment. This project aims to examine the phylogenetic structure of ....Subspecies distribution and virulence of Streptococcus uberis. Streptococcus uberis is a significant cause of bovine mastitis. Attempts to produce a successful vaccine against S. uberis have been hampered by the lack of knowledge of phylogenetic relationships within the species and virulence mechanisms. It is uncertain whether pathogenic strains are clonal or are acquired opportunistically from a diverse population in the environment. This project aims to examine the phylogenetic structure of S. uberis by multilocus sequence typing and investigate control of virulence gene expression in S. uberis. The information obtained will be used to improve the formulation of a bovine mastitis vaccine developed by RMIT University and Vet Biosearch.Read moreRead less
Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situation ....Evaluation of the potential of colostrum-derived anti-influenza antibody for the treatment and prevention of influenza. The project addresses a common disease problem, influenza, with a novel application of antibody technology. The technology may safely provide protection and cost effective treatment for those members of the community who are least protected by current approaches. The product can be cost-effective and readily available to enable the public to self medicate in high risk situations, or to be used as a public health tool in situtions to control outbreaks in those most susceptible to serious disease. The production system that enabled the creation of the technology is the advanced Australian dairy industry. Farmers with herds participating will receive a significant income benefit from, what was before, largely a waste product.Read moreRead less
Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala ....Developing a chlamydial vaccine for koalas. Developing a chlamydial vaccine for koalas . This project aims to produce an optimised, safe, field-tested, protective Chlamydia vaccine for koalas. In many regions of Australia, Chlamydia infection severely reduces female koala reproductive rates, threatening the species’ long term survival. This project builds on work developing a prototype vaccine for koala Chlamydia, and intends to produce a vaccine ready for potential registration and use by koala care centres, wildlife hospitals and government departments.Read moreRead less
Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in ....Development of a vaccine to protect koalas against koala retrovirus (KoRV). This project aims to develop a vaccine against koala retrovirus (KoRV) to arrest the increasing loss of animals due to this infection. Along with Chlamydia, KoRV threatens the long-term survival of the koala. KoRV infects over 95 per cent of Australia’s koalas and has been strongly linked to lymphoma and leukemia. Although quarantine and antiretroviral drug treatment are possible control measures, they are impractical in the wild, leaving vaccination as the only realistic option. This is valuable for both wild and captive koalas; zoos report high animal losses due to KoRV-associated lymphoma. The main outcome will be a KoRV vaccine which can be combined with a Chlamydia vaccine which is being developed in parallel.Read moreRead less